BioRestorative Therapies Announces Activation of Northwell Health in the Companys Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

MELVILLE, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that Northwell Health, New York State’s largest health care provider, has been activated and can now start recruitment…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *